Sunbelt Securities’s Bionano Genomics BNGO Stock Holding History

Sunbelt Securities’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-13	Closed	-$4	–	2718
2025 Q2	$4	Buy	+13	New	+$48	﹤0.01%	1801
2025 Q1	–	Hold	0	–	-$4	–	1810
2024 Q4	–	Hold	0	–	–	–	1805
2024 Q3	–	Hold	0	–	–	–	1843

Other funds holding BNGO

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CAM

Carret Asset Management New York $1.02B AUM 26.95% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sunbelt Securities's BNGO Position: Q3 2025 in Review

Sunbelt Securities sold out of Bionano Genomics (BNGO) in Q3 2025, closing a stake of 13 shares — an estimated $4 sold.

Sunbelt Securities first reported a position in BNGO in Q2 2025 and held it in 1 quarter. The position peaked at $4 in Q2 2025. 32 funds tracked by Wall St. Rank hold BNGO as of Q3 2025.

Sunbelt Securities reported no remaining Bionano Genomics position as of Q3 2025 after selling out during the quarter.
Sunbelt Securities sold 13 Bionano Genomics shares in Q3 2025, an estimated $4.
Sunbelt Securities first reported a position in Bionano Genomics in Q2 2025 and held it in 1 quarter.
Sunbelt Securities's Bionano Genomics position peaked at $4 in Q2 2025.
32 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2025.

Based on Sunbelt Securities's 13F filing for Q3 2025, filed 19 Nov 2025.